Search results for "OUTCOME"

showing 10 items of 5148 documents

Subepithelial connective tissue graft with or without enamel matrix derivative for the treatment of Miller class I and II gingival recessions: a cont…

2012

Background The aim of this study was to evaluate whether the combination of enamel matrix derivative (EMD) with subepithelial connective tissue graft (SCTG) plus coronally advanced flap (CAF) would improve the treatment outcomes of Miller class I and II gingival recessions when compared with the same technique (SCTG plus CAF) alone. Methods The study was designed as a randomized, parallel, controlled, double-blinded clinical trial. Forty-two patients were randomly assigned in the test group (SCTG plus EMD) and in the control group (SCTG). Patients had at least one gingival recession ≥ 2 mm. The clinical parameters were evaluated at baseline and at 14 d, 1, 3, 6 and 12 mo follow-up time poin…

Adultmedicine.medical_specialtyTest groupTreatment outcomeGingivaDentistrySubepithelial connective tissue graftEsthetics DentalSurgical FlapsRoot Planinglaw.inventionYoung AdultDental Enamel ProteinsDouble-Blind MethodRandomized controlled triallawEnamel matrix derivativemedicineHumansPeriodontal PocketGingival RecessionTooth RootGingival recessionbusiness.industryMean ageMiddle AgedSurgeryTreatment OutcomeConnective TissuePhotography DentalKeratinsPeriodonticsmedicine.symptombusinessAfter treatmentFollow-Up StudiesJournal of Periodontal Research
researchProduct

Reconstructive plastic surgery in the treatment of vulvar carcinomas

2005

Abstract Objective The results obtained using plastic surgery reconstruction in 207 patients with a primary or recurrent vulvar carcinoma were analyzed with regard to the surgical procedures applied, pre-treatment and post-operative findings, along with the long-term oncological disease course. Study design Standardized data concerning the surgical procedures applied and clinical factors were collected in a databank and statistically analyzed. Results The flaps employed were termed either ‘local' (cutaneous or fasciocutaneous; n =84) or ‘regional' (myocutaneous, n =123). For local flaps, the rate of secondary healing was 31%, dropping to 20% for regional flaps. Such healing disturbances oft…

Adultmedicine.medical_specialtyThighSurgical FlapsDisease courseGynecologic Surgical ProceduresmedicineHumansSecondary healingAgedAged 80 and overRecurrent Vulvar CarcinomaWound HealingVulvar Neoplasmsbusiness.industryAdvanced stageObstetrics and GynecologyMiddle AgedPlastic Surgery Proceduresmedicine.diseaseSurvival AnalysisSurgeryPlastic surgeryStenosisTreatment Outcomemedicine.anatomical_structureReproductive MedicineFemaleVulvar CarcinomaNeoplasm Recurrence LocalbusinessEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

Immune Tolerance Induction in Hemophilia A: A Review

2003

In this article, a comparative analysis of the data stemming from the studies conducted in the field of immune tolerance treatment (ITT) of hemophilia A was attempted. Comparisons are difficult because previous studies differ in many respects, including the dosage of factor (F) VIII, the number of FVIII administrations per day, the association with immunosuppressive drugs (prednisone, cyclophosphamide), and, most importantly, the definition of success in terms of the reacquisition of tolerance. However, a number of variables consistently influenced outcome: the inhibitor titer, either the maximum one or the one assayed before immune tolerance (IT) start and age. As to the FVIII dose, result…

Adultmedicine.medical_specialtyTime FactorsAdolescentDoseCyclophosphamideHemophilia AImmune toleranceVon Willebrand factorPrednisoneInternal medicineImmune ToleranceCoagulopathyHumansMedicineChildFactor VIIIbiologybusiness.industryInfantHematologymedicine.diseaseRecombinant ProteinsKineticsTreatment OutcomeChild PreschoolImmunologyChemoprophylaxisbiology.proteinCardiology and Cardiovascular MedicinebusinessBypassing agentmedicine.drugSeminars in Thrombosis and Hemostasis
researchProduct

THE OPTIMIZATION OF INTERFERON FOR MS STUDY: 375 MICROG INTERFERON BETA-1B IN SUBOPTIMAL RESPONDERS.

2008

We aimed to evaluate the safety and MRI efficacy of interferon beta-1b (IFNbeta-1b) 375 microg (subcutaneously [sc] every other day [eod]) in relapsing-remitting multiple sclerosis (RRMS) patients with a suboptimal response to IFNbeta-1b 250 microg, i.e., with MRI activity or relapses. The OPTimization of Interferon for MS (OPTIMS) study was a prospective multicenter randomized phase 2 trial comprising a 6-month run-in phase (to identify suboptimal responders) and a 6-month randomized phase of open-label clinical and blinded MRI follow-up. During run-in all patients were treated with IFNbeta-1b 250 microg sc eod; during the study phase suboptimal treatment responders were randomized either …

Adultmedicine.medical_specialtyTime FactorsAdolescentInjections Subcutaneoussuboptimal treatment responseGastroenterologyDrug Administration Schedulelaw.inventionYoung AdultMultiple Sclerosis Relapsing-RemittingAdjuvants ImmunologicRandomized controlled triallawInternal medicinemedicineHumansSingle-Blind MethodProspective StudiesAdverse effectProspective cohort studyinterferon beta (IFNβ)immunomodulatory drugSubclinical infectionDose-Response Relationship Drugbusiness.industryInterferon beta-1bInterferon-betaMiddle AgedMagnetic Resonance ImagingConfidence intervalSurgeryClinical trialTreatment OutcomeNeurologyRelative riskmultiple sclerosiMRI activitySettore MED/26 - NeurologiaNeurology (clinical)businessFollow-Up StudiesInterferon beta-1b
researchProduct

Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients

2015

Abstract Objective We aim to assess the effect of metformin treatment on metabolic parameters, endothelial function and inflammatory markers in polycystic ovary syndrome (PCOS) subjects. Methods The study population consisted of 40 reproductive-age women with PCOS, who underwent treatment with metformin during a 12-week period, and their corresponding matched controls (n = 44). We evaluated endocrinological parameters, adhesion molecules (vascular cell adhesion molecule 1 (VCAM-1), intercellular cell adhesion molecule 1 (ICAM-1) and E-selectin) and proinflammatory cytokines (interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFα)) in serum. In addition, interactions between human umbili…

Adultmedicine.medical_specialtyTime FactorsAdolescentendocrine system diseasesEndotheliumType 2 diabetesProinflammatory cytokineYoung AdultInsulin resistanceInternal medicineCell AdhesionHuman Umbilical Vein Endothelial CellsLeukocytesmedicineHumansLeukocyte RollingEndothelium Leukocyte Metformin Mitochondria PCOS Type 2 diabetesCells CulturedCell adhesion moleculebusiness.industryEndothelial Cellsnutritional and metabolic diseasesmedicine.diseasePolycystic ovaryCoculture TechniquesMetforminMetforminEndothelial stem cellTreatment Outcomemedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 2SpainCytokinesFemaleInflammation MediatorsCardiology and Cardiovascular MedicinebusinessCell Adhesion MoleculesBiomarkersPolycystic Ovary Syndromemedicine.drugAtherosclerosis
researchProduct

Chimney and periscope grafts to facilitate endovascular treatment of aortic transection in a patient with aberrant right subclavian artery

2014

Purpose: To report the use of parallel grafts to extend the proximal landing zone for stentgraft repair of aortic transection involving an aberrant right subclavian artery (ARSA). Case Report: A 28-year-old patient was referred for treatment of traumatic aortic transection with contained rupture at the level of an ARSA. Immediate thoracic endovascular aortic repair (TEVAR) was planned because of hemodynamic instability. To achieve rapid sealing and maintain perfusion to both subclavian arteries, a chimney stent to the left subclavian artery (LSA) and a periscope stent-graft to the ARSA were deployed successfully. After surgical repair of all fractures, the patient was discharged 1 month aft…

Adultmedicine.medical_specialtyTime FactorsAortic RuptureCardiovascular AbnormalitiesSubclavian ArteryHemodynamics610 Medicine & healthProsthesis DesignAortographySettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineBlood Vessel Prosthesis ImplantationBlood vessel prosthesisX ray computedmedicine.arterymedicineHumansThoracic aorta2741 Radiology Nuclear Medicine and ImagingRadiology Nuclear Medicine and imagingcardiovascular diseasesEndovascular treatmentAortabusiness.industryEndovascular ProceduresHemodynamicsAberrant right subclavian arteryVascular System InjuriesAneurysmBlood Vessel ProsthesisSurgery10020 Clinic for Cardiac Surgery2746 SurgeryTreatment Outcomesurgical procedures operativeRegional Blood FlowLanding zonecardiovascular systemStentsSurgeryAneurysm surgeryRadiologyDeglutition DisordersTomography X-Ray ComputedCardiology and Cardiovascular Medicinebusinessthoracic aorta aortic transection trauma thoracic endovascular aortic repair aberrant right subclavian artery left subclavian artery stent-graft parallel graft chimney graft periscope graft landing zone
researchProduct

Endovascular Embolization of a Large High-Flow Splenic Arteriovenous Fistula and Aneurysm Using the Amplatzer Vascular Plug II.

2015

We describe the use of an Amplatzer Vascular Plug (AVP) II for embolizing a large high-flow splenic arteriovenous fistula and an aneurysm in a young patient. This patient presented to our center with persistent mild abdominal discomfort, 5 years after open splenectomy. Contrast-enhanced computed tomography angiography showed the presence of a fistula between the splenic arterial and splenic venous remnants and a resultant fusiform aneurysmal dilatation of the residual splenic vein. We decide to embolize the splenic artery with a 12-mm diameter AVP II with an oversizing by 70% of the vessel diameter. Celiac angiography performed 5 min postembolization revealed complete obliteration of the sp…

Adultmedicine.medical_specialtyTime FactorsFistulamedicine.medical_treatmentSplenectomyArteriovenous fistula030204 cardiovascular system & hematologySplenic arteryRadiation Dosage030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineAneurysmmedicine.arterymedicineHumansEmbolizationComputed tomography angiographymedicine.diagnostic_testbusiness.industryAngiography Digital SubtractionGeneral MedicineRadiation Exposuremedicine.diseaseAneurysmEmbolization TherapeuticSurgeryTreatment OutcomeSplenic veinRegional Blood FlowSplenic VeinArteriovenous FistulaSplenectomySurgeryFemaleRadiologyCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedSplenic ArteryBlood Flow VelocityAnnals of vascular surgery
researchProduct

The effect of prenatal lifestyle intervention on weight retention 12 months postpartum: results of the Norwegian Fit for Delivery randomised controll…

2015

Objective To examine the effect of a prenatal lifestyle intervention on postpartum weight retention (PPWR). Design Randomised controlled trial. Setting Healthcare clinics in southern Norway. Population Healthy, nulliparous women with body mass index ≥19 kg/m2 , age ≥18 years, and singleton pregnancy of ≤20 gestational weeks. Methods Women were randomised to intervention (dietary counselling twice by phone and access to twice-weekly exercise groups during pregnancy) or control group (standard prenatal care). Intervention compliance was defined post-factum as attending dietary counselling and ≥14 exercise classes. Main outcome measures PPWR (weight measured postpartum minus self-reported pre-…

Adultmedicine.medical_specialtyTime FactorsPopulationPrenatal careWeight Gainlaw.inventionBody Mass Index03 medical and health sciences0302 clinical medicineRandomized controlled triallawPregnancyRisk FactorsmedicineHumans030212 general & internal medicineObesityeducationExerciseLife StylePregnancyeducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryObstetricsNorwayPostpartum PeriodPregnancy OutcomeObstetrics and GynecologyPrenatal CareOdds ratioVitaminsmedicine.diseasePregnancy ComplicationsPhysical therapyFemalemedicine.symptombusinessBody mass indexWeight gainPostpartum periodBJOG : an international journal of obstetrics and gynaecology
researchProduct

Data comparison between pharmacological induction of labour and spontaneous delivery. A single centre experience.

2016

Objectives: To assess the differences in the maternal and fetal outcomes between pharmacological induced and sponta­neous labour in nulliparous women. Material and methods: Observational cohort study carried out over a period of 2 years. Inclusion criteria: nulliparous sin­gleton pregnancies, with cephalic fetal presentation, elective labour induction with intra-vaginal prostaglandin E2 (PGE2) gel (Prepidil® 2 mg) at a gestational age of 41 weeks. Control group: patients who entered labour spontaneously at a gestational age of ≥ 40 weeks. The main demographic maternal characteristics and intra- and postpartum data were extracted from computer records and obstetrics diaries and were used for…

Adultmedicine.medical_specialtyTime FactorsProstaglandin E2Cohort Studies03 medical and health sciences0302 clinical medicineObstetrics and gynaecologyPregnancy030225 pediatricsSpontaneous labourOxytocicsInduction of labourMedicineInduction of labour Neonatal outcome Prostaglandin E2 Spontaneous labour Medicine (all) Obstetrics and GynecologyHumans030212 general & internal medicineLabor InducedProstaglandin E2reproductive and urinary physiologyGynecologyFetusbusiness.industryObstetricsInfant NewbornPregnancy OutcomeObstetrics and GynecologyGestational ageSpontaneous labourFetal PresentationNeonatal outcomeDelivery ObstetricSingle centreProstaglandinsFemalebusinessCohort studymedicine.drugGinekologia polska
researchProduct

Treating Cockroach Phobia With Augmented Reality

2009

In vivo exposure is the recommended treatment of choice for specific phobias; however, it demonstrates a high attrition rate and is not effective in all instances. The use of virtual reality (VR) has improved the acceptance of exposure treatments to some individuals. Augmented reality (AR) is a variation of VR wherein the user sees the real world augmented by virtual elements. The present study tests an AR system in the short (posttreatment) and long term (3, 6, and 12 months) for the treatment of cockroach phobia using a multiple baseline design across individuals (with 6 participants). The AR exposure therapy was applied using the "one-session treatment" guidelines developed by Öst, Salko…

Adultmedicine.medical_specialtyTime FactorsPsychotherapistmedicine.medical_treatmentExposure therapyCockroachesVirtual realityUser-Computer InterfaceYoung AdultPhysical medicine and rehabilitationSurveys and Questionnairesbiology.animalmedicineAnimalsHumansPsychiatric Status Rating ScalesCockroachAr systembiologymedicine.diseaseClinical PsychologyTreatment OutcomeMultiple baseline designPhobic DisordersFemaleAugmented realityPsychologyAfter treatmentAnxiety disorderFollow-Up StudiesBehavior Therapy
researchProduct